Clinical Trials Logo
  1. Home
  2. Hospital-Acquired Pneumonia
  3. NCT04403971

0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia

Hospital-acquired Pneumonia Clinical Trial

Official title:
Effect of 0.12% Chlorhexidine Oral Care for the Prevention of Non-ventilator Hospital-acquired Pneumonia Among Hospitalized Patients

Clinical Trial Summary

Chlorhexidine is a effective strategy in reducing ventilator associated pneumonia. However, it is unclear if prophylactic 0.12% chlorhexidine oral rinse can reduce the risk of non-ventilator hospital-acquired pneumonia among hospitalized patients.

Clinical Trial Description

Participants will be classified into three groups, applied twice a day by care givers. Oral colonization will be tested in the baseline, day-3, day-7, and at the discharge. Quantitation of colonization of the oral cavity by oral rinses and respiratory pathogens were measured. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04403971
Study type Interventional
Source National Cheng-Kung University Hospital
Contact
Status Completed
Phase N/A
Start date May 25, 2020
Completion date December 31, 2020
View Details
See also
  Status Clinical Trial Phase
Completed NCT01266863 - E Test Strips Applied to Bronchoalveolar Lavage for Suspicion of Hospital-acquired Pneumonia to Accelerate Antibiogram Analysis. N/A
Not yet recruiting NCT06168734 - Cefepime-taniborbactam vs Meropenem in Adults With VABP or Ventilated HABP Phase 3
Not yet recruiting NCT01940731 - Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults Phase 2
Not yet recruiting NCT06028217 - Chinese Hospital Acquired Pneumonia Collaboration Network: Epidemiology, Diagnosis and Treatment
Completed NCT01561469 - Evaluation of Patients With Methicillin-Resistant Staphylococcus Aureus Hospital-Acquired Pneumonia Treated With Linezolid or Vancomycin N/A
Terminated NCT00543608 - Clinical Efficacy of Intravenous Iclaprim Versus Vancomycin in the Treatment of Hospital-Acquired, Ventilator-Associated, or Health-Care-Associated Pneumonia Phase 2
Enrolling by invitation NCT04055922 - Comparison of Solid Organ Transplant
Completed NCT04774094 - Efficacy and Safety of Ceftazidime-Avibactam (CAZ-AVI) in Chinese Participants With HAP (Including VAP) Phase 4
Completed NCT05060718 - HOspital NEtwork STudy - Preparation for a Randomized Evaluation of Anti-Pneumonia Strategies
Active, not recruiting NCT05785442 - Use of Presepsin as a Marker for Immunotherapy Administration in Pneumonia Phase 2
Completed NCT04700202 - Identifying Risk Factors for Gram-negative Resistance for HAP/VAP in the Intensive Care Unit
Not yet recruiting NCT05418517 - Hospital Acquired Pneumonia in Temporary Tracheostomy
Recruiting NCT04381247 - Comprehensive Molecular Diagnosis and Management of Hospital- and Ventilator-associated Pneumonia in Norway
Recruiting NCT05483309 - Feasibility Study of Contemporary Diagnostics for Patients With Suspected Hospital-Acquired Pneumonia. N/A
Completed NCT04937075 - Impact of Antimicrobial Stewardship on Outcomes of Patients With Hospital-acquired Pneumonia Due to Gram-negative Bacilli - A Before-after Study
Completed NCT03496220 - Effect of Angulus on Patient-elevation Compliance N/A
Not yet recruiting NCT05914584 - "Baricitinib for Treating Hospital-acquired Pneumonia in Critically Ill Patients With a Proinflammatory Phenotype. Phase 2/Phase 3
Completed NCT05663905 - Efficacy of Intravenous Amboxol Hydrochloride as an Adjunct Therapy for Severe Pneumonia in Critically Ill Patients Phase 4
Terminated NCT03361085 - Modular Prevention Bundle for Non-ventilator-associated Hospital-acquired Pneumonia (nvHAP) N/A
Completed NCT05624684 - Diagnostic Performance and Impact of a Multiplex PCR Pneumonia Panel in ICU Patients With Severe Pneumonia.